Member-only story
The Case for Semaglutides: Why Doesn’t the Market Want You Healthy?
The promise of a healthier populace faces resistance — not just from societal habits but powerful industries with vested interests in maintaining the status quo. Why doesn’t the market want you healthy?
4 min readJun 25, 2024
The Case for Semaglutides: Why Doesn’t the Market Want You Healthy?
In the realm of groundbreaking medical advancements, semaglutides stand out as a revolutionary force in the fight against obesity.
These GLP-1 receptor agonists, originally developed to treat type 2 diabetes, have shown profound efficacy in weight loss. With results surpassing traditional methods, semaglutides are poised to redefine how we tackle obesity. However, the promise of a healthier populace faces resistance — not just from societal habits but powerful industries with vested interests in maintaining the status quo.
Why doesn’t the market want you healthy?
Big Pharma: Profits Over Prevention
The Status Quo
The pharmaceutical industry is a behemoth, with profits deeply entrenched in chronic disease…
